SlideShare une entreprise Scribd logo
1  sur  27
PHARMACOECONOMICS ,[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Preview
PHARMACOECONOMICS RESEARCH ,[object Object],[object Object],[object Object],[object Object]
VALUE Health Outcome Cost
USE OF PHARMACOECONOMIC RESEARCH ,[object Object],[object Object],[object Object],[object Object],[object Object]
NEEDS TO MONITOR VALUE OF PHARMACEUTICALS ,[object Object],[object Object],[object Object],[object Object]
TYPES OF PHARMACOECONOMIC EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object]
COMPARING PHARMACOECONOMIC METHODOLOGIES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
STEPS FOR CONDUCTING A PHARMACOECONOMIC EVALUATION ,[object Object],[object Object],[object Object],[object Object]
DEFINE THE PROBLEM AND STATE THE OBJECTIVE ,[object Object],[object Object]
PERSPECTIVE ,[object Object],[object Object],[object Object],[object Object]
PERSPECTIVE ,[object Object]
IDENTIFYING ALTERNATIVE INTERVENTIONS ,[object Object]
IDENTIFYING ALTERNATIVE INTERVENTIONS ,[object Object]
IDENTIFY AND MEASURE OUTCOMES OF EACH ALTERNATIVE INTERVENTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
OUTCOMES ,[object Object],[object Object],[object Object]
IDENTIFYING,MEASUREMENT AND VALUATION OF COSTS ,[object Object],[object Object]
IDENTIFYING RELEVANT COSTS ,[object Object],[object Object]
COSTS ,[object Object],[object Object],[object Object]
Costs can be described in many ways ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MEASURING COSTS ,[object Object],[object Object]
VALUING COSTS ,[object Object]
SENSITIVITY ANALYSIS ,[object Object],[object Object]
DISCOUNTING ,[object Object],[object Object]
JOURNALS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
REFERENCES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ASSIGNMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Studies in health economics
Studies in health economicsStudies in health economics
Studies in health economicsTanveerRehman4
 
Clinical pharmacy by Atef Gabr
Clinical pharmacy by Atef GabrClinical pharmacy by Atef Gabr
Clinical pharmacy by Atef GabrAtef Gabr
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.shahvijita
 
Cost effectiveness analysis - seminar kmu peshawar
Cost effectiveness analysis - seminar kmu peshawarCost effectiveness analysis - seminar kmu peshawar
Cost effectiveness analysis - seminar kmu peshawarAamer Naseer
 
Pharmacometrics 2.2.17
Pharmacometrics 2.2.17Pharmacometrics 2.2.17
Pharmacometrics 2.2.17Dr. Md Yaqub
 
Quantification of medicines need
Quantification of medicines needQuantification of medicines need
Quantification of medicines needMmedsc Hahm
 
Recent Advances in migraine
Recent Advances in migraine Recent Advances in migraine
Recent Advances in migraine DR ANUP PETARE
 
Intro to pharmacoeconomics
Intro to pharmacoeconomicsIntro to pharmacoeconomics
Intro to pharmacoeconomicssamthamby79
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluationVeena Suresh
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyVibha Manu
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsZainab&Sons
 

Tendances (20)

Studies in health economics
Studies in health economicsStudies in health economics
Studies in health economics
 
Clinical pharmacy by Atef Gabr
Clinical pharmacy by Atef GabrClinical pharmacy by Atef Gabr
Clinical pharmacy by Atef Gabr
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.
 
Cost effectiveness analysis - seminar kmu peshawar
Cost effectiveness analysis - seminar kmu peshawarCost effectiveness analysis - seminar kmu peshawar
Cost effectiveness analysis - seminar kmu peshawar
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacometrics 2.2.17
Pharmacometrics 2.2.17Pharmacometrics 2.2.17
Pharmacometrics 2.2.17
 
Quantification of medicines need
Quantification of medicines needQuantification of medicines need
Quantification of medicines need
 
Recent Advances in migraine
Recent Advances in migraine Recent Advances in migraine
Recent Advances in migraine
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
Pharmacometrics
PharmacometricsPharmacometrics
Pharmacometrics
 
Intro to pharmacoeconomics
Intro to pharmacoeconomicsIntro to pharmacoeconomics
Intro to pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Drug utilisation studies
Drug utilisation studiesDrug utilisation studies
Drug utilisation studies
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Politerapia. Dott. Mauro Zanocchi
Politerapia. Dott. Mauro ZanocchiPoliterapia. Dott. Mauro Zanocchi
Politerapia. Dott. Mauro Zanocchi
 

En vedette

Pharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSAPharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSAStevce Acevski
 
Evaluating Health Technology Assessment Reports and New Assessment Techniques...
Evaluating Health Technology Assessment Reports and New Assessment Techniques...Evaluating Health Technology Assessment Reports and New Assessment Techniques...
Evaluating Health Technology Assessment Reports and New Assessment Techniques...bpstat
 
Hol webinar summary
Hol webinar summaryHol webinar summary
Hol webinar summaryCameron Tew
 
Pharmacoeconomic moh program 1
Pharmacoeconomic moh program 1Pharmacoeconomic moh program 1
Pharmacoeconomic moh program 1Noura Aljohani
 
Pharmacoeconomic Assessment through Market Approval and Beyond
Pharmacoeconomic Assessment through Market Approval and BeyondPharmacoeconomic Assessment through Market Approval and Beyond
Pharmacoeconomic Assessment through Market Approval and BeyondMedpace
 
Basics of pharmacoeconomics_and_outcomes_research (2)
Basics of pharmacoeconomics_and_outcomes_research (2)Basics of pharmacoeconomics_and_outcomes_research (2)
Basics of pharmacoeconomics_and_outcomes_research (2)Arlen Meyers, MD, MBA
 
Josh feldstein hopr (presentation)
Josh feldstein hopr (presentation)Josh feldstein hopr (presentation)
Josh feldstein hopr (presentation)jonblanck
 
The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...Sax Institute
 
HTA training - Dr Roisin Adams - March 27th 2016
HTA training - Dr Roisin Adams - March 27th 2016HTA training - Dr Roisin Adams - March 27th 2016
HTA training - Dr Roisin Adams - March 27th 2016ipposi
 
Pharmacoeconomics by harsh
Pharmacoeconomics by harshPharmacoeconomics by harsh
Pharmacoeconomics by harshHarsh Yadav
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmDDr.Sohel Memon
 
Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Naser Tadvi
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyDivjyot Kaur
 
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig UniversityHistology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig Universityguestd708a83
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics CLARAsteven7
 
Pharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisPharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisMohammed Mohammed
 
Neoplasia Etiology and pathogenesis of cancer
Neoplasia Etiology and pathogenesis of cancerNeoplasia Etiology and pathogenesis of cancer
Neoplasia Etiology and pathogenesis of cancerSubramani Parasuraman
 

En vedette (20)

Pharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSAPharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSA
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Pharmacoeconomics seminar
Pharmacoeconomics seminarPharmacoeconomics seminar
Pharmacoeconomics seminar
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Evaluating Health Technology Assessment Reports and New Assessment Techniques...
Evaluating Health Technology Assessment Reports and New Assessment Techniques...Evaluating Health Technology Assessment Reports and New Assessment Techniques...
Evaluating Health Technology Assessment Reports and New Assessment Techniques...
 
Hol webinar summary
Hol webinar summaryHol webinar summary
Hol webinar summary
 
Pharmacoeconomic moh program 1
Pharmacoeconomic moh program 1Pharmacoeconomic moh program 1
Pharmacoeconomic moh program 1
 
Pharmacoeconomic Assessment through Market Approval and Beyond
Pharmacoeconomic Assessment through Market Approval and BeyondPharmacoeconomic Assessment through Market Approval and Beyond
Pharmacoeconomic Assessment through Market Approval and Beyond
 
Basics of pharmacoeconomics_and_outcomes_research (2)
Basics of pharmacoeconomics_and_outcomes_research (2)Basics of pharmacoeconomics_and_outcomes_research (2)
Basics of pharmacoeconomics_and_outcomes_research (2)
 
Josh feldstein hopr (presentation)
Josh feldstein hopr (presentation)Josh feldstein hopr (presentation)
Josh feldstein hopr (presentation)
 
The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...
 
HTA training - Dr Roisin Adams - March 27th 2016
HTA training - Dr Roisin Adams - March 27th 2016HTA training - Dr Roisin Adams - March 27th 2016
HTA training - Dr Roisin Adams - March 27th 2016
 
Pharmacoeconomics by harsh
Pharmacoeconomics by harshPharmacoeconomics by harsh
Pharmacoeconomics by harsh
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
 
Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig UniversityHistology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisPharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysis
 
Neoplasia Etiology and pathogenesis of cancer
Neoplasia Etiology and pathogenesis of cancerNeoplasia Etiology and pathogenesis of cancer
Neoplasia Etiology and pathogenesis of cancer
 

Similaire à Pharmacoeconomics1

Outcomes, health economics and pharmacoeconomics
Outcomes, health economics and  pharmacoeconomicsOutcomes, health economics and  pharmacoeconomics
Outcomes, health economics and pharmacoeconomicsDureshahwar khan
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsIjeh Cyril
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1jinender16
 
Pharmacoeconomics.ppt
Pharmacoeconomics.pptPharmacoeconomics.ppt
Pharmacoeconomics.pptPabitra Thapa
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsZainab&Sons
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDYSuvarta Maru
 
Seminar pharmacoeconomics
Seminar pharmacoeconomicsSeminar pharmacoeconomics
Seminar pharmacoeconomicsSameerKhasbage
 
Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Dr Roohana Hasan
 
Pharmacoeconomis
PharmacoeconomisPharmacoeconomis
PharmacoeconomisAanchal46
 
Principles of Pharmacoeconomics and ...
Principles of Pharmacoeconomics and                                          ...Principles of Pharmacoeconomics and                                          ...
Principles of Pharmacoeconomics and ...Aasritha William
 
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...Is complementary and alternative medicine (CAM) cost-effective? a systematic ...
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...home
 
Pharmacoeconomics & pharmacoepidemioology
Pharmacoeconomics &  pharmacoepidemioologyPharmacoeconomics &  pharmacoepidemioology
Pharmacoeconomics & pharmacoepidemioologyDivya singh
 
pharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfpharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfKRIMSExamination
 
Pharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfPharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfSudipta Roy
 

Similaire à Pharmacoeconomics1 (20)

Outcomes, health economics and pharmacoeconomics
Outcomes, health economics and  pharmacoeconomicsOutcomes, health economics and  pharmacoeconomics
Outcomes, health economics and pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Pharmacoeconomics ii
Pharmacoeconomics iiPharmacoeconomics ii
Pharmacoeconomics ii
 
Pharmacoeconomics.ppt
Pharmacoeconomics.pptPharmacoeconomics.ppt
Pharmacoeconomics.ppt
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
 
Seminar pharmacoeconomics
Seminar pharmacoeconomicsSeminar pharmacoeconomics
Seminar pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018
 
PHARMACOECONOMICS.pptx
PHARMACOECONOMICS.pptxPHARMACOECONOMICS.pptx
PHARMACOECONOMICS.pptx
 
Pharmacoeconomis
PharmacoeconomisPharmacoeconomis
Pharmacoeconomis
 
Pharmacoeconomis
PharmacoeconomisPharmacoeconomis
Pharmacoeconomis
 
Principles of Pharmacoeconomics and ...
Principles of Pharmacoeconomics and                                          ...Principles of Pharmacoeconomics and                                          ...
Principles of Pharmacoeconomics and ...
 
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...Is complementary and alternative medicine (CAM) cost-effective? a systematic ...
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...
 
Pharmacoeconomics & pharmacoepidemioology
Pharmacoeconomics &  pharmacoepidemioologyPharmacoeconomics &  pharmacoepidemioology
Pharmacoeconomics & pharmacoepidemioology
 
pharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfpharmacoeconomic_models.pdf
pharmacoeconomic_models.pdf
 
Pharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfPharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdf
 

Plus de jinender16

Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinenderjinender16
 
Patient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To PhysiciansPatient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To Physiciansjinender16
 
Pseudoephedrine
PseudoephedrinePseudoephedrine
Pseudoephedrinejinender16
 
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical IndustryDirect To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industryjinender16
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinenderjinender16
 

Plus de jinender16 (9)

ISPOR
ISPORISPOR
ISPOR
 
Poster
PosterPoster
Poster
 
Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinender
 
APha Poster
APha PosterAPha Poster
APha Poster
 
Patient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To PhysiciansPatient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To Physicians
 
Singapore
SingaporeSingapore
Singapore
 
Pseudoephedrine
PseudoephedrinePseudoephedrine
Pseudoephedrine
 
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical IndustryDirect To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinender
 

Pharmacoeconomics1

  • 1.
  • 2.
  • 3.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.